Affiliation:
1. Federal State Autonomous Educational Institution of Higher Education I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
2. Federal State Autonomous Educational Institution of Higher Education I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Federal State Budgetary Educational Institution of Additional Professional Education “Russian Medical Academy of Continuous Professional Education”, Ministry of Health of Russia
3. Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology (RSCRR) of the Ministry of Healthcare of the Russian Federation (Russian Scientific Center of Roentgenoradiology)
Abstract
Thymic neoplasms account for 20 – 25% of primary mediastinal tumors. Nonspecific clinical symptoms are often associated with delayed diagnosis of thymoma, leading to a distinctive problem of late diagnosis. Nowadays, surgical removal of the tumor is the method of choice for thymoma treatment. Combination treatment is indicated in the case of an unresectable tumor. Modern therapy (various combinations of anticancer drugs) helps reduce neoplasm size, stop metastasis, and maintain good quality of life in patients with thymoma.Aim. The presented clinical case of type B3 thymoma (with invasion into surrounding organs and metastatic pleura) is characterized by a long asymptomatic period of the disease, the onset of symptoms after suffering COVID-19 (COronaVIrus Disease 2019) and successful long-term polychemotherapy. The causes of late diagnosis, as well as insufficient oncologic vigilance in evaluating the results of laboratory and instrumental tests, are discussed based on this clinical case.Conclusion. A correct diagnosis, as well as successful treatment, requires a multidisciplinary approach involving physicians from different specialties – general practitioners, oncologists, surgeons, radiologists, and morphologists.
Publisher
Scientific and Practical Reviewed Journal Pulmonology
Subject
Pulmonary and Respiratory Medicine
Reference17 articles.
1. Barbolina T.D., Bychkov M.B., Allakhverdiyev A.K. et al. [Practical recommendations for drug treatment of thymus tumors (thymomas and thymic cancer). Zlokachestvennye opukholi. 2020; 10 (3s2-1): 603–614. Available at: https://rosoncoweb.ru/standarts/RUSSCO/2020/2020-35.pdf (in Russian).
2. Robinson S.P., Akhondi Y. Thymoma. In: StatPearls [Internet].Treasure Island (FL): StatPearls Publishing; 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK559291/
3. Yıldırım F., Mutlu M.Y., İçaçan OC., Bes C. Dermatomyositis associated with thymoma: a case report and literature review. Clin. Ter. 2023; 174 (2): 115–120. DOI: 10.7417/CT.2023.2506.
4. Álvarez-Velasco R., Gutiérrez-Gutiérrez G., Trujillo J.C. et al. Clinical characteristics and outcomes of thymoma-associated myasthenia gravis. Eur. J. Neurol. 2021; 28 (6): 2083–2091. DOI: 10.1111/ene.14820.
5. Liao C.H., Lyu S.Y., Chen Y.C. et al. Thymoma-related paraneoplastic syndrome mimicking reactive arthritis. Medicina. 2021, 57 (9): 932. DOI: 10.3390/medicina57090932.